SynerGraft To Enter European Clinicals In Early 2000; IDE To Follow
This article was originally published in The Gray Sheet
Executive Summary
CryoLife plans to submit an investigational device exemption in the U.S. for the SynerGraft porcine heart valve following the successful completion of European trials slated to being in late 1999 or early 2000.